Skip to content

Clinical trials

Terminated Melanoma trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Melanoma Status: Terminated Country / region: Belgium Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20052
20061
20081
20092
20101
20123
20141
20151
20174
20183
20192
20203
20215
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated32

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals5
Bristol-Myers Squibb3
Cliniques universitaires Saint-Luc- Université Catholique de Louvain3
Amgen2
GlaxoSmithKline2
Ludwig Institute for Cancer Research2
Pfizer2
ADC Therapeutics S.A.1
Aprea Therapeutics1
BioNTech US Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Melanoma32
Carcinoma, Non-Small-Cell Lung9
Neoplasm Metastasis4
Pancreatic Neoplasms3
Triple Negative Breast Neoplasms3
Brain Neoplasms2
Carcinoma, Renal Cell2
Colorectal Neoplasms2
Neoplasms2
Skin Neoplasms2

Trials

Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.